title: What happened to patients with behavioural and psychological symptoms of dementia (BPSD) after the Committee on Safety in Medicines (CSM) guidelines?
authors.affiliation: Mersey Care NHS Trust, Waterloo Day Hospital, Liverpool, UK.
authors.forename: Jukanti
authors.initials: J
authors.lastname: Raju
authors.forename: Sudip
authors.initials: S
authors.lastname: Sikdar
authors.forename: T
authors.initials: T
authors.lastname: Krishna
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000008:administration & dosage; D000075202:Contraindications; D003704:Dementia / Q000188:drug therapy* / Q000523:psychology*; D004334:Drug Administration Schedule; D004363:Drug Utilization / Q000706:statistics & numerical data; D004739:England; D005260:Female; D006707:Homes for the Aged; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic; D018967:Risperidone
chemical_list: D014150:Antipsychotic Agents; D018967:Risperidone